The Gemini Study was a 14-week, open-label, non-comparative, office-based, multicenter trial to evaluate single-pill therapy in the treatment of concomitant hypertension and dyslipidemia. In addition ...
Please provide your email address to receive an email when new articles are posted on . AACE published its first updated guideline on the pharmacologic management of adults with dyslipidemia since ...
A new dyslipidemia guideline from the American Association of Clinical Endocrinology (AACE) offers evidence-based recommendations for the use of newer drugs and focuses on outcomes that are important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback